Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
4.060
+0.160 (4.10%)
At close: Jun 6, 2025, 4:00 PM
4.060
0.00 (0.00%)
After-hours: Jun 6, 2025, 4:57 PM EDT

Jaguar Health Stock Forecast

JAGX's stock price has decreased by -95.86% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Jaguar Health stock has a target of 60, which predicts a 1,377.83% increase from the current stock price of 4.06.

Price Target: $60.00 (+1,377.83%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $60 $60 $60 $60
Change +1377.8% +1377.8% +1377.8% +1377.8%

Analyst Ratings

According to 1 stock analyst, the rating for Jaguar Health is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '25May '25Jun '25
Strong Buy 011
Buy 100
Hold 000
Sell 000
Strong Sell 000
Total 111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
First Berlin
First Berlin
Strong Buy
Initiates
$60
Strong Buy Initiates $60 +1,377.83% May 19, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$1,687,500
Buy Initiates $1,687,500 +41,563,939.41% Jul 7, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
14.31M
from 11.69M
Increased by 22.41%
Revenue Next Year
18.60M
from 14.31M
Increased by 30.00%
EPS This Year
-24.29
from -130.69
EPS Next Year
-5.79
from -24.29
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
9.39M4.34M11.96M9.76M11.69M14.31M18.60M
Revenue Growth
62.51%-53.81%175.80%-18.36%19.75%22.41%30.00%
EPS
----2,678.17-130.69-24.29-5.79
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 14.7M 19.1M
Avg 14.3M 18.6M
Low 13.7M 17.9M

Revenue Growth

Revenue Growth 20252026
High
26.0%
33.8%
Avg
22.4%
30.0%
Low
17.6%
24.9%

EPS Forecast

EPS 20252026
High -25.00 -5.96
Avg -24.29 -5.79
Low -23.33 -5.57

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.